APRE ▲ +4.7% - Aprea Therapeutics, Inc. $APRE - Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs Aprea Therapeutics shares rose 4.7% following the company's announcement of an expanded intellectual property portfolio for its precision oncology programs. The expansion of IP protections typically strengthens a company's competitive position by extending patent coverage and potential exclusivity periods for its drug candidates, which investors view as a positive development for long-term value creation. 28-AUG-2026 08:15 AM ET